Publications
-
Berrueco R, Sebastián E, Solsona M, González de Pablo J, Ruiz-Llobet A, Mesegue-Meda M, Gálvez E and Sevilla J.
Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres
ACTA PAEDIATRICA . 110(6): 1952-1958. Number of citations: 4
-
Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives-Solà S, Ramirez M and Camós-Guijosa M.
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Frontiers in pediatrics . 8: 614521-614521. Number of citations: 5
-
Ortíz-Maldonado V, Rives-Solà S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballero-Baños M, Baumann T, Jordi Cid Colom, Garcia-Rey E, Llanos C, Torrebadell-Burriel M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català-Temprano A, Faura A, González EA, Español-Rego M, Klein-González N, Alsina L, Castro P, Jordán-García I, Fernández S, Ramos F, Suñé G, Perpiñá U, Canals JM, Lozano M, Trias E, Scalise A, Varea S, Sáez-Peñataro J, Torres F, Calvo G, Esteve J, Urbano-Ispizua Á, Juan-Otero M and Delgado J.
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies
MOLECULAR THERAPY . 29(2): 636-644. Number of citations: 91
-
Deyà-Martinez A, Alonso-Saladrigues A, García, AP, Faura, A, Torrebadell-Burriel M, Vlagea, A, Català-Temprano A, Esteve-Solé A, Juan-Otero M, Rives-Solà S and Alsina L.
Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia
BONE MARROW TRANSPLANTATION . 56(2): 376-386. Number of citations: 12
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Number of citations: 25
-
Buechner J, Grupp SA, Hiramatsu H, Teachey DT, Rives-Solà S, Laetsch TW, Yanik GA, Wood P, Awasthi R, Yi L, Chassot-Agostinho A, Eldjerou LK and De Moerloose B.
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy
blood advances . 5(2): 593-601. Number of citations: 35
-
Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.
Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome
HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1.
-
Levine JE, Grupp SA, Pulsipher MA, Dietz AC, Rives-Solà S, Myers GD, August KJ, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Baruchel A, Boyer MW, De Moerloose B, Qayed M, Davies SM, Phillips CL, Driscoll TA, Bader P, Schlis K, Wood PA, Mody R, Yi L, Leung M, Eldjerou LK, June CH and Maude SL.
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
Journal for ImmunoTherapy of Cancer . 9(8): 2287. Number of citations: 38
-
Torrents S, Alonso L, Vives J, Rodríguez L, Moron-Cazalilla G, Elorza-Alvarez I, Uria ML, Benitez MI, Parody R, Orti G, Trabazo M, Fernandez-Sojo J, Badell-Serra I and Querol S.
Good Response Rates of WJ-MSC, Comparable to BMMSC, in the Treatment of Refractory GVHD
BONE MARROW TRANSPLANTATION . 55(s1): 269-270.
-
Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragán E, Fernandez-Isern G, Hernández-Sánchez JM, Martín-Izquierdo M, Maynou-Fernández J, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Solà S, Dapena JL, Ramírez M and Camós-Guijosa M.
Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
Journal of Personalized Medicine . 10(4): 244. Number of citations: 1